Tisteron Ltd) 1 New Body Waste Management Device A Business Opportunity.
-
Upload
jennifer-byrd -
Category
Documents
-
view
214 -
download
0
Transcript of Tisteron Ltd) 1 New Body Waste Management Device A Business Opportunity.
Tisteron Ltd)
1
New Body Waste Management Device
A Business Opportunity
Tisteron Ltd, Israel
Company established to develop, patent & license the Body Waste Management Device idea
Ron Chen, Founder & Inventor - Israel
Moshe Goldwasser, Inventor/Consultant – Retired CEO of Avgol Inc.
Tisteron Ltd
2
YNC – Yoav Nir Consulting Independent consultant specialist for the Nonwoven and
disposable absorbent industry. Registered mentor with the Israeli Ministry of Industry &
Trade Certified business master coach (MCI & EMCI) Former COO and then for 15 years CEO of a privately held
company that produces and markets disposable absorbent products.
Prominent Achievements Competing successfully against multinational consumer product
giants Successfully running the company during times of war Bringing the company from a state of bankruptcy to success Leading major business strategy changes
Tisteron Ltd (CONFIDENTIAL)
3
Shlomo Eylath is a consultant with Tisteron regarding strategic business decisions and business development.
Founder of Shlomo Eylath Holdings Ltd., a private company which focuses on management & consulting services including M&A, turnaround and recovery plans. Also serves on boards of numerous companies
Co-founder of ColBar Life Science [160M$ exit to J&J] Former CEO Koor Food and Consumer Goods Ltd. (The
largest food conglomerate in Israel) Former CEO Koor-Trade UK Ltd.
Tisteron Ltd
4
A DISPOSABLE WASTE CONTAINMENT ARTICLE AND A COMBINATION OF TWO ARTICLES WORN SIMULTANEOUSLY CIP of Provisional Application Filed: 20.09.2006 Full patent filed: 17.09.2007
Granted April 19, 2011, Patent No US7927320 B2.pdf Individual use of articles; Liquid-impermeable outer layers, perimeter seal inward from outer
perimeter; Pulp-less absorbent layer; Aperture for body waste intake; Adhesive for securing to body; Examiner recommended that a two-piece system be
separated from patent and become a separate application. Tisteron submitted a separate application, which is expected to be granted.
Tisteron has also applied for PCT and approval is still pending.
Tisteron Ltd
5
CANADA, MEXICO, BRAZIL, JAPAN, AUSTRALIA, ISRAEL
E.P.O. -U.K, GERMANY, ITALY, TURKEY, FRANCE, SPAIN, THE NETHERLANDS, BELGIUM, SWEDEN, DENMARK, POLAND
Tisteron Ltd
6
Separate body waste collection
Articles worn singly or in tandem – Separate patent pending
Feces (bacteria) separated from urine Only soiled device has to be changed Support undergarment envisioned
Tisteron Ltd
7
Attaches w/gentle adhesive surrounding orifice, sealing article(s) to body Less skin area to cleanse Odors and fecal matter captured in
“sealed” containers Very thin and expands as fills Very soft & compliant to shape of body Simple manufacturing envisioned
Tisteron Ltd
8
Carried out in geriatric ward of a leading nursing home in Israel, overseen by Mr. Goldwasser & Dr. Korshun
The conclusion of trials in the nursing home was that the product is most effective for independent users suffering from incontinence
Tisteron Ltd
9
Suitable for collection of body waste by independent patients
Users can replace devices themselves independently more easily than a diaper when needed
More comfortable than diaper & releases less odors
Tisteron Ltd
10
Better protection against leakage (seepage) when attached properly
Less skin irritation, even with sensitive skin
Hydro gel adhesive functions even in the presence of contaminants
Tisteron Ltd
11
Dignity Less leakage Less odor (waste totally contained) Less exposure of private parts (genitalia)
Comfort Easily applied and removed (Hydro gel adhesive) Low bulk Enhanced mobility Almost unnoticeable under clothing
Healthier, less damage to skin (Hydro gel adhesive/less skin exposed to waste)
Easily applied and removed Less exposure to body waste Less patient care cost, due to:
Longer wear time Less space required for storage & disposal Less skin health care expenses
Tisteron Ltd
12
Reduced Cost Fewer devices used per day by patient Less space required for new product
warehousing Less labor required for:
Changes Clean-up Laundry
Fewer dermatological problems Less waste for disposal
Patients & caregivers are more content Less foul atmospheric aromas in wards Improved market competitiveness (more
advantageous for patient/family)
Tisteron Ltd
13
Easily applied and removed Less bulky Less patient maneuvering required
Less clean-up Skin Garments Bedding
Less leakage and odors after use Used device totally enclosed in sealed bag
Less dermatological issues Lower costs
Tisteron Ltd
14
User’s dignity Preserved “Green” product
Less raw material consumed Less waste for disposal Use of “Green” materials in specifications &
claims Low volume, hence less transportation/unit,
etc. Fewer trucks Less fuel Less storage space
In summary – less costs with regard to: Overall patient care Materials, waste, transportation, storage,
health, labor, etc.
Tisteron Ltd
15
Tisteron Ltd
16
Example of use during carotid artery operation – replacing catheter
Redesign apertures’ size and location
Redesign adhesive aperture measurements
Design devices with various containment volume capacity
Redesign device shape for better fit & convenience
Tisteron Ltd
17
1. Absorbent layer carrier/over wrap feeding2. Glue application3. SAP application4. Over wrap folding5. Absorbent layer sealing & cutting6. Top sheet feed7. Hydro gel sticker cutting & application8. Cutting out aperture9. Backsheet feed10. Front & Backsheet merge 11. Glue, seal & cut12. Product group completed & stacked (folded or
unfolded)13. Packaging
Tisteron Ltd
18
Tisteron Ltd
19
2 Lines
Lines 1 2 3 4Investment $1,500,000 $3,000,000 $4,500,000 $6,000,000
Shifts
Daily Capacity (85% efficiency)1 183,600 367,200 550800 734,4002 367,200 734,400 1101600 1,468,8003 550,800 1,101,600 1652400 2,203,200
Area required (Sqm) 1200 2000 3000 4000Rent (Inc. Municipals) $/Sqm $7.00 $7.00 $7.00 $7.00 $7.00
Working days per month 25 25 25 25 25Interest rate 5% 5% 5% 5%
Years 5 5 5 5Working Capital Financing period Months 3 3 3 3
Direct labor As calculatedManufacturing cost On sales 3.5% 3.5% 3.5% 3.5%
Distribution, Sales On sales 12.0% 12.0% 12.0% 12.0%G&A On sales 1.50% 1.50% 1.50% 1.50%
Hourly Machine Capacity 183,600 Speed (units/minute) 450
Hours/shift 8Efficiency 85%
New business opportunity
Novel solution to real need
Patents granted & pending
Products assembled from readily available resources/technology
Optimization & commercialization open for discussion
Tisteron Ltd
20
Thank You
Tisteron Ltd
21